Research News 2
Research News
-
Timing Is Everything
Timing of ART initiation after infection determines vulnerability of the HIV reservoir, the main barrier to a cure
-
Uganda’s Anti-Homosexuality Law Cannot Stand
amfAR criticizes Uganda Constitutional Court’s refusal to strike down its Anti-Homosexuality Act, citing HIV healthcare and human rights violations.
-
Creating a Cost-Effective Cure
Researchers design a highly potent latency reversing agent that targets the HIV reservoir, the main barrier to a cure, and boosts immune responses.
-
Rejuvenating the Field of AIDS Research
Three promising young HIV researchers—Drs. Gabriel Duette, Kalen Petersen, and Simone Richardson—have been awarded amfAR’s Mathilde Krim Fellowship in Biomedical Research.
-
New Studies Advance HIV Cure Science
HIV cure researchers, including amfAR grantees, report findings on post-treatment control, HIV reservoirs, and early treatment in children at CROI
-
A Person-Centered Cure
An amfAR-funded study examined the attitudes and needs of HIV cure trial participants—people living with HIV who go off antiretrovirals to test certain strategies.
-
What’s the Role of Natural Killer Cells in Curing HIV?
Description: A study coauthored by amfAR grantee Dr. Timothy Schacker suggests a way to decrease HIV-producing cells in lymphatic tissue.
-
Enhancing Innate Immunity Against HIV
Researchers find clues to HIV cure strategies in the immunity profile of elite controllers, people living with HIV who can control the virus without medications.
-
Importance of the Brain as an HIV Reservoir
Researchers bring sharper focus to a not-very-accessible HIV cure target.
-
COVID-19, Pregnancy, and Protection
Researchers discover immune mechanisms that protect fetuses of SARS-CoV-2-infected mothers from COVID-19’s ill effects.
-
New Case of Post-Treatment Control
Researchers in the Netherlands report on a man who has been undetectable without being on antiretrovirals for almost two decades.
-
Overcoming Toxicities Associated with Virus-Based Gene Therapy
Fine-tuning an HIV cure strategy, an amfAR researcher considers ways to deliver gene therapy with care.
-
amfAR Grantee Dr. Drew Weissman Awarded Nobel Prize
2023 Nobel Prize in Medicine awarded to Drs. Drew Weissman and Katalin Karikó for pioneering mRNA research leading to COVID-19 vaccines.
-
Combining CAR T Cell Strategies to Achieve an HIV Cure
amfAR researchers re-engage with anti-HIV CAR T cell therapies by exploring new ways to enhance their activity.
-
How Does the HIV Reservoir Avoid Destruction?
Researchers define new ways that latent HIV, the main barrier to a cure, evades destruction by the immune system’s natural killer cells.